The tweet was deleted by the author.
But we saved everything 🙂.
Eli Lilly and Company has announced a significant $3 billion investment in a new manufacturing site in Katwijk, Netherlands.
This move aims to enhance global access to oral medicines, building on Eli Lilly's ongoing expansion efforts in the United States. The investment underscores the company's commitment to delivering treatments to a broader range of patients more swiftly. Further details about their manufacturing and quality commitment can be found on their official site.